Delivery Order SPE2DB22D3501-SPE2DB24FXB36
Award Date
9/24/24
Potential Completion Date
10/16/24
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, a pharmaceutical product. The contract has a ceiling value of $1,202.28 and runs through September 25, 2024. It is a Firm Fixed Price contract. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,220.94, is for the supply of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, a medical product. The contract has an ultimate completion date of April 1, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $9,722.10 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4,564,743,440 units of the pharmaceutical product GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, with a completion date of June 20, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which allows the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $14,427.24 firm fixed-price contract is for the supply of GAMUNEX-C, a 40 gram/400 ml vial pharmaceutical product, with a completion date of September 30, 2024. The order is not associated with any set-aside program. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to provide a wide range of medications and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 5 gram/50 ml vials, a pharmaceutical product, with a ceiling value of $1,518.35. The contract is a firm fixed-price delivery order and is not set aside for any socioeconomic program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,530.00 contract is for the supply of GAMUNEX-C 20 gram/200 ml vials, with a performance period through December 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,133,843 units of the pharmaceutical product GAMUNEX-C 20 gram/200 ml vial. The contract has a ceiling value of $7,147.50 and a period of performance through April 22, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of GAMUNEX-C 40 gram/400 ml vial, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $9,618.16, is a firm fixed-price delivery order with a completion date of July 23, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, to provide a...
This is a firm fixed-price delivery order worth $7,213.68, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract is for the delivery of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, a pharmaceutical product, with a completion date of September 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as part of its extensive federal contracting activities to supply a wide range of essential medical...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $23,869.12, is for the supply of GAMUNEX-C 20 gram/200 ml vials to support military treatment programs and facilities. The contract has a completion date of February 26, 2024 and does not include any set-aside designations. Amerisourcebergen Drug Corp...